SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Filing Date
Mar 31, 2017
Document Date
May 10, 2017
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS INC